Cyanogen Bromide as DehydrosulfurizingAgent for the Synthesis of Nβ-Fmoc-AminoAlkyl Isonitriles from Nβ-Fmoc-AminoAlkyl Thioformamides by Vishwanatha, T. M. et al.
LETTER1096
Cyanogen Bromide as Dehydrosulfurizing Agent for the Synthesis of Nb-Fmoc-
Amino Alkyl Isonitriles from Nb-Fmoc-Amino Alkyl Thioformamides
Dehydrosulfurizing Agent for the Synthesis of Nb-Fmoc-Amino Alkyl IsonitrilesT. M. Vishwanatha, H. P. Hemantha, V. V. Sureshbabu*
Peptide Research Laboratory, Department of Studies in Chemistry, Central College Campus, Dr. B. R. Ambedkar Veedhi, 
Bangalore University, Bangalore 560001, India
E-mail: sureshbabuvommina@rediffmail.com; E-mail: hariccb@hotmail.com
Received 28 September 2009
SYNLETT 2010, No. 7, pp 1096–1100xx.xx.2010
Advanced online publication: 16.03.2010
DOI: 10.1055/s-0029-1219583; Art ID: D27609ST
© Georg Thieme Verlag Stuttgart · New York
Abstract: Synthetically useful Nb-Fmoc amino alkyl isonitriles are
prepared conveniently from Nb-Fmoc amino alkyl thioformamides
via a cyanogen bromide mediated dehydrosulfurization. The reac-
tion is fast, clean, and yields are good.
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In recent years, the synthetic utility of isonitriles1 in or-
ganic reactions has been exploited. Compounds contain-
ing an isocyano group find use as antibiotics,2
antineoplastics,3 and antianaesthetics.4 The synthetic util-
ity of isonitriles arises from their divergent character5 and
this functionality has wide utility, such as in the prepara-
tion of isothiocyanates,6 N,N-dialkylcarbodiimides,7 1-
substituted tetrazoles,8 pyrazoles,9 oxazoles,10 and thiaz-
oles.11 The use of isonitriles in multicomponent reactions
such as the Passerini12 and Ugi13 reactions for generating
a wide variety of biologically important derivatives of
peptides,14 glycopeptides,15 and other peptidic
molecules16–20 has been well demonstrated.
In peptide chemistry, the application of isonitrile deriva-
tives of amino acids has led to a variety of
peptidomimetics21 and other useful products such as b-
lactams,22 glycopeptides,23 depsipeptides,24 peptide nucle-
ic acids,25 and N-hydroxy peptides.26 Amino acid ester de-
rived isonitriles are the known entities, which are
prepared from corresponding formyl amino acid esters.27
A recent entry into this new class of amino acid derived
isonitriles has been described by our group wherein Nb-
Fmoc amino alkyl isonitriles were obtained through car-
boxyl group modification.28
Of the many methods available for the preparation of
isonitriles, dehydration of formamides is the widely fol-
lowed route in amino acid chemistry, showing general ap-
plicability and reproducibility.29 Reaction of alkyl halides
with heavy metal cyanide salts,30 addition of dichloro-
carbene to amines,31 reduction of isocyanates and
isothiocyanates32 are other available routes. Dehydration
of formamides has been carried out by using tosyl chlo-
ride, phosphorus oxychloride (POCl3) in the presence of a
base, cyanuric chloride, triphenyl phosphine–CCl4, phos-
gene, diphosgene, and triphosgene.33 The method em-
ploying POCl3 being quite harsh is found to cause
racemization and therefore is not applicable in peptide
chemistry, and isolation of enantiomerically pure isoni-
triles is always challenging and demanding. Danishefsky
and co-workers have isolated enantiomerically pure a-
isocyanoesters34 derived from formyl amino acid esters,
employing triphosgene/N-methylmorpholine (NMM) at
–78 °C. Nenajdenko’s group has synthesized the amino
acid derived nonracemic isonitriles employing the less
commonly used 4-methyl-2,6,7-trioxabicyclo[2.2.2]
octyl-protected formyl amino ester.35 Sureshbabu et al. re-
ported the synthesis and isolation of enantiomerically
pure N-Fmoc-amino alkyl isonitriles by the dehydration
of the corresponding Nb-Fmoc amino alkyl formamides
under neutral conditions employing Burgess’ reagent.28 In
a continuation of our current studies on isonitriles, we
sought a simple and economically viable route involving
dehydrosulfurization of Nb-Fmoc amino alkyl thioforma-
mides using cyanogen bromide (CNBr, Scheme 1).
Scheme 1
There has been a surge in the synthesis of thio analogues
of peptides and related intermediates, the replacement of
O with S yielding novel unnatural amino acids and pepti-
domimetics such as thiopeptides,36 thioureas, and
isothiocyanates37 possessing therapeutic importance. Sul-
fur-containing compounds such as thioamides and
thioesters have been found to be better reactants in the
preparation of several heterocycle-tethered peptido-
mimetics and other related compounds compared to their
oxygenated analogues.38,39 Furthermore, some thioform-
amides show antifungal40 and antibacterial activity,41 and
they have been employed in the synthesis of thiazoles via
the Hantzsch protocol.42 We envisaged the use of N-
urethane-protected amino alkyl thioformamides for the
synthesis of the corresponding isonitriles through a dehy-
drosulfurization reaction. In a patent, Ugi had demonstrat-
ed the conversion of thioformamides into their respective
isonitriles using CNBr.43 However, this protocol has yet to
be exploited to its full advantage although the method
shows promise.44,45 Thus, in the present communication,
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we describe the synthesis of Nb-Fmoc amino alkyl thiofor-
mamides and their conversion to isonitriles employing cy-
anogen bromide as the dehydrosulfurization reagent.
In the first part of this study, we undertook the preparation
of Nb-Fmoc amino alkyl thioformamides, a hitherto unre-
ported class of molecules, by the thionation of the corre-
sponding formamides. Starting with a Nb-Fmoc amino
acid, the carboxyl group was converted to its formamide
under Gold–Schmidt–Wick formolysis of the correspond-
ing isocyanate using formic acid/DMAP.46 On treating a
solution of N-Fmoc-Ala-Y[CH2NHCHO] 5b in THF with
an equimolar quantity of P2S5 at room temperature, the re-
spective thioformamide was obtained within an hour in
satisfactory yield and purity after a flash chromatography.
By way of optimization, a suspension of N-Fmoc-Ala-
Y[CH2NHCHO] 5b (1 mmol) and P2S5 (0.7 mmol) in
THF was subjected to ultrasonication at 25 °C. To our sat-
isfaction, the reaction was complete in 15 minutes as
judged by TLC, and the product was isolated after flash
chromatography in excellent yield (Scheme 2) and enan-
tiomeric purity.47 The protocol was then successfully ex-
tended to other amino acids as well to prepare a series of
Nb-Fmoc-amino alkyl thioformamides 1a–j,49,50 and the
products were isolated as stable solids after purification in
92–96% yield and adequately characterized (Table 1).
In the next step, conversion of the thioformamides into
isonitriles was undertaken.48 Accordingly, a reaction of
thioformamide 1 with CNBr (1.5 mmol) in the presence of
NMM in dry CH2Cl2 at 0 °C afforded the corresponding
isonitrile 251,52 within 30 minutes (Scheme 1). The reac-
tion was rapid and complete, and the product was isolated
after chromatography in excellent yield as a stable solid.
When the reaction was carried out at room temperature, a
considerable drop in the yield of isonitrile 1 (up to 20%)
was incurred. Reproduceable results were obtained when
the protocol was employed for dehydrosulfurization of
several other Nb-Fmoc amino alkyl thioformamides. All
the compounds were isolated as stable solids (Table 1)
whose physical properties matched those previously re-
ported by us28 and were also further characterized spectro-
scopically. Thus dehydrosulfurization of thioformamides
is more efficient when compared to the dehydration of
formamides for the synthesis of isonitriles.
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Table 1 List of Thioformamides 1 and Isonitriles 2 
Compd Thioformamide 1 Mp (°C) HRMS [M + Na]+ 
(found/calcd)
Isonitrile 2 Mp (°C) HRMS [M + H]+ 
(found/ calcd)
a 141 349.0978/349.0987 165
293.1031/
293.1200
b 105 363.1132/363.1143 112
307.1346/
307.1368
c 118 439.1443/439.1456 128
383.1672/
383.1681
d 126 391.1438/391.1456 101
335.1672/
335.1681
e 117 405.1603/405.1613 109
349.1816/
349.1838
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The conditions employed in the synthesis of isonitriles
were scrutinized to check for the possibility of racemiza-
tion during the reaction. Two dipeptide thioformamides
1k,l, prepared by the reaction of alanyl alkyl isonitrile
with Fmoc-D/L-Phg-OH, were converted into their re-
spective dipeptidyl isonitriles 2k,l following the protocol
described above. The 1H NMR spectra possessed methyl
doublets of the Ala residue of 2k and 2l at d = 1.16, 1.18
ppm and at d = 1.23, 1.24 ppm, respectively, indicating the
presence of a single epimer in each sample, a conclusion
which was also supported by HPLC data. Furthermore,
the N-Fmoc-peptidyl isonitrile obtained by the reaction of
an equimolar mixture of Fmoc-L/D-Phg-OH with  alanyl
alkyl thioformamide followed by dehydrosulfurization
showed two separate doublets for the alanyl methyl group
in the 1H NMR spectrum, once again demonstrating the
absence of epimerization.
In summary, we have described an efficient synthesis of
Nb-Fmoc-amino alkyl isonitriles by the dehydrosulfuriza-
tion of corresponding thioformamides employing CNBr.
This protocol provides an alternative efficient method for
the preparation of the title compounds in high yields.
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Scheme 3
(49) Typical Experimental Procedure for 1a–j
To a stirred solution of Nb-Fmoc amino alkyl formamide 5 
(1 mmol) in THF (5 mL), P2S5 (0.7 mmol) was added. The 
reaction mixture was subjected to ultrasonication for 15 min. 
After the completion of reaction (TLC), the solvent was 
evaporated in vacuo, and the crude was purified by a flash 
chromatography to obtain the thioformamides as solids.
(50) Selected Spectroscopic Data.
Compound 1b: 1H NMR (400 MHz, CDCl3): d = 1.30 (d, 3 
H, J = 6.53 Hz), 2.65 (d, 2 H), 3.90 (m, 1 H), 4.20 (t, 1 H, 
J = 13.04 Hz), 4.41 (d, 2 H, J = 6.62 Hz), 5.01 (br, 1 H), 7.31 
(t, 2 H, J = 14.79 Hz), 7.39 (t, 2 H, J = 14.69 Hz), 7.57 (d, 2 
H, J = 7.21 Hz), 7.76 (d, 2 H, J = 7.48 Hz), 8.20 (s, 1 H). 13C 
NMR (100 MHz, CDCl3): d = 17.44, 46.83, 47.18, 56.18, 
66.83, 122.24, 124.93, 127.08, 128.17, 141.34, 143.66, 
155.77, 139.31.
Compound 1j: 1H NMR (400 MHz, CDCl3): d = 2.39–2.65 
(m, 2 H), 3.12–3.51 (m, 2 H), 3.1 (m, 1 H), 4.10 (t, 1 H, 
J = 6.90 Hz), 4.12 (d, 2 H, J = 7.2 Hz), 4.74 (s, 2 H), 5.56 (br, 
1 H), 7.15–7.80 (m, 13 H), 8.25 (s, 1 H). 13C NMR (100 
MHz, CDCl3; CCl4): d = 36.91, 43.06, 46.82, 51.89, 65.83, 
69.82, 119.15, 124.90, 126.25, 127.53, 128.12, 128.24, 
141.67, 143.53, 143.81, 156.38, 139.22, 171.58.
Compound 1k: 1H NMR (400 MHz, CDCl3): d = 1.14 (d, 3 
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H, J = 5.0 Hz), 2.65–3.16 (m, 2 H), 4.05–4.20 (m, 3 H), 4.22 
(d, 2 H, J = 8.0 Hz), 6.65 (br, 1 H), 6.88 (br, 1 H), 7.28–7.48 
(m, 8 H), 7.56 (d, 2 H, J = 4.0 Hz), 7.74 (d, 2 H, J = 8.0 Hz), 
8.16 (s, 1 H). 13C NMR (100 MHz, CDCl3): d = 17.12, 43.09, 
45.86, 53.69, 58.29, 67.18, 125.34, 126.22, 127.09,127.77, 
128.01, 128.40, 128.63, 135.54, 141.30, 143.75, 159.14, 
156.29, 138.9.
(51) Typical Experimental Procedure for 2a–j
A solution of Nb-Fmoc amino alkyl thioformamide 1 (1 
mmol) in dry CH2Cl2 (10 mL) was cooled to 0 °C, NMM 
(2 mmol) and CNBr (1.5 mmol) were added, and the reaction 
mixture was stirred at this temperature for 30 min. After 
completion of reaction, it was diluted with CH2Cl2 (10 mL) 
and was washed with H2O, brine, and dried over anhyd 
Na2SO4. The solvent was evaporated under reduced pressure 
followed by chromatographic purification (silica gel, 100–
200 mesh, 20% EtOAc in hexane) to afford the desired 
isonitriles 2 in excellent yield and purity as stable solids.
(52) Selected Spectroscopic Data
Compound 2c: IR (KBr): nmax = 1715, 2149 cm–1. 1H NMR 
(400 MHz, CDCl3): d = 2.81 (br, 2 H), 3.12–3.65 (m, 2 H), 
3.95 (br, 1 H), 4.12 (br, 1 H), 4.29 (d, 2 H, J = 4.0 Hz), 5.15 
(br, 1 H), 7.17 (m, 9 H), 7.44 (d, 2 H, J = 8.0 Hz), 7.69 (d, 2 
H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3): d = 37.30, 
44.39, 47.19, 50.79, 66.99, 120.10, 125.04, 127.15, 127.35, 
127.84, 129.03, 129.10, 135.98, 141.38, 143.65, 155.55, 
158.45.
Compound 2f: IR (KBr) nmax = 1710, 2151 cm–1. 1H NMR 
(400 MHz, CDCl3): d = 2.20–2.71 (m, 2 H), 3.00–3.59 (m, 4 
H), 4.00 (br, 1 H), 4.12 (d, 1 H, J = 7.8 Hz), 4.41 (br, 2 H), 
6.02 (s,1 H), 7.00–7.74 (m, 13 H). 13C NMR (100 MHz, 
CDCl3): d = 32.10, 36.21, 44.00, 46.85, 49.12, 53.34,66.88, 
119.90, 124.82, 126.95, 127.08, 127.83, 128.15, 136.77, 
141.00, 143.13, 155.11, 158.10.
Compound 2l: IR (film/pellet) nmax = 1715, 2151 cm–1. 1H 
NMR (400 MHz, CDCl3): d = 1.24 (d, 3 H, J = 4.0 Hz), 
3.12–3.79 (m, 2 H), 3.87–4.10 (m, 3 H), 4.11 (d, 2 H, J = 8.0 
Hz), 5.09 (br, 1 H), 5.89 (br, 1 H), 7.28–7.48 (m, 8 H), 7.56 
(d, 2 H, J = 4.0 Hz), 7.74 (d, 2 H, J = 8.0 Hz), 8.18 (s, 1 H). 
13C NMR (100 MHz, CDCl3): d = 17.00, 43.69, 46.42, 54.10, 
57.95, 67.10, 119.77, 125.45, 127.22, 127.75, 128.53, 
128.40, 128.63, 135.09, 141.30, 143.75, 154.94, 156.49, 
170.97.
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